In 2024, the global coronary stents market was valued at USD 6.68 billion. It is expected to grow from USD 7.02 billion in 2025 to USD 10.66 billion by 2032, registering a compound annual growth rate (CAGR) of 6.2% during the forecast period. North America led the market in 2024, accounting for a dominant share of 33.08%.
The coronary stents market plays a vital role in the treatment of coronary artery disease, offering minimally invasive solutions to restore blood flow in blocked or narrowed arteries. These small, expandable devices are widely used in angioplasty procedures to support arterial walls and reduce the risk of future blockages. With the increasing prevalence of cardiovascular diseases, changing lifestyles, and advancements in interventional cardiology, demand for coronary stents continues to grow. Innovations such as drug-eluting stents, bioresorbable stents, and improved stent delivery systems are enhancing clinical outcomes and patient recovery. As healthcare systems prioritize faster, safer, and more effective treatment options, the coronary stents market is poised for continued evolution and global expansion.
Continue reading for more details:
**https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065**
Market Segmentation
The coronary stents market is segmented by product type, material, end-user, and region. By product type, the market includes bare-metal stents, drug-eluting stents, and bioresorbable stents, each offering unique benefits for different patient conditions. Based on material, the market is categorized into metallic and polymer-based stents. In terms of end-users, hospitals, ambulatory surgical centers, and cardiac specialty clinics are the primary consumers. Regionally, the coronary stents market is analyzed across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, each showing varying levels of market penetration and demand trends.
List Of Key Coronary Stents Market Companies Profiled:
Market Growth